Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Rossignol

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
European Journal of Haematology|December 16, 2019
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II resultJean-Marie Michot, Maxime Annereau, Alina Danu, et al.
Frontiers in Neuroscience|December 7, 2017
Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's DiseaseAbeer Al-Gharaibeh, Rebecca Culver, Andrew N Stewart, et al.
Frontiers in Immunology|January 11, 2021
Mobilized Multipotent Hematopoietic Progenitors Stabilize and Expand Regulatory T Cells to Protect Against Autoimmune EncephalomyelitisSarantis Korniotis, Maud D'Aveni, Sébastien Hergalant, et al.
Journal of Cellular and Molecular Medicine|February 10, 2010
Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantationJulien Rossignol, Cécile Boyer, Reynald Thinard, et al.
Stem Cell Research & Therapy|March 2, 2019
A novel approach to label bone marrow-derived mesenchymal stem cells with mixed-surface PAMAM dendrimersNikolas Munro, Bhairavi Srinageshwar, Firas Shalabi, et al.
Behavioral Neuroscience|May 31, 2012
Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's diseaseKyle D Fink, Julien Rossignol, Andrew T Crane, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphomaJean-Marie Michot, Alice Buet-Elfassy, Maxime Annereau, et al.
British Journal of Haematology|October 15, 2021
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registryThibault Comont, Mael Heiblig, Etienne Rivière, et al.
International Journal of Molecular Sciences|March 25, 2017
PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J MiceBhairavi Srinageshwar, Sarah Peruzzaro, Melissa Andrews, et al.
Stem Cells Translational Medicine|March 25, 2014
Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's diseaseKyle D Fink, Andrew T Crane, Xavier Lévêque, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
European Journal of Haematology|December 16, 2019
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II resultJean-Marie Michot, Maxime Annereau, Alina Danu, et al.
Frontiers in Neuroscience|December 7, 2017
Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's DiseaseAbeer Al-Gharaibeh, Rebecca Culver, Andrew N Stewart, et al.
Frontiers in Immunology|January 11, 2021
Mobilized Multipotent Hematopoietic Progenitors Stabilize and Expand Regulatory T Cells to Protect Against Autoimmune EncephalomyelitisSarantis Korniotis, Maud D'Aveni, Sébastien Hergalant, et al.
Journal of Cellular and Molecular Medicine|February 10, 2010
Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantationJulien Rossignol, Cécile Boyer, Reynald Thinard, et al.
Stem Cell Research & Therapy|March 2, 2019
A novel approach to label bone marrow-derived mesenchymal stem cells with mixed-surface PAMAM dendrimersNikolas Munro, Bhairavi Srinageshwar, Firas Shalabi, et al.
Behavioral Neuroscience|May 31, 2012
Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's diseaseKyle D Fink, Julien Rossignol, Andrew T Crane, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphomaJean-Marie Michot, Alice Buet-Elfassy, Maxime Annereau, et al.
British Journal of Haematology|October 15, 2021
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registryThibault Comont, Mael Heiblig, Etienne Rivière, et al.
International Journal of Molecular Sciences|March 25, 2017
PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J MiceBhairavi Srinageshwar, Sarah Peruzzaro, Melissa Andrews, et al.
Stem Cells Translational Medicine|March 25, 2014
Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's diseaseKyle D Fink, Andrew T Crane, Xavier Lévêque, et al.
Pageof 14